THE SOCIETY OF UROLOGIC ONCOLOGY
Balance Sheet
Fiscal Year Start:
May 1
Assets in 2024 (Year End)
$8,209,357
Cash & Equivalents
55%
Other Assets
42%
Prepaid Expenses
2%
Receivables (Non-Related)
1%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$207,617
Deferred Revenue
55%
Payables & Accruals
45%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$4,014,602
$4,544,525
+13%
Receivables (Non-Related)
$40,465
$84,891
+110%
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$153,899
$172,134
+12%
Investments
$0
$0
-
Property, Plant, & Equipment (net)
$0
$0
-
Other Assets
$3,047,937
$3,407,807
+12%
Total Assets
$7,256,903
$8,209,357
+13%
Liabilities
2023
2024
Change
Payables & Accruals
$223,189
$94,350
-58%
Grants Payable
-
-
-
Deferred Revenue
$334,300
$113,267
-66%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$557,489
$207,617
-63%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$6,699,414
$8,001,740
+19%
Net assets
2023
2024
Change
Net assets
+$6,699,414
+$8,001,740
+19%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)